Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Aehr Test Systems (NASDAQ: AEHR) was $20.19 for the day, down -0.74% from the previous closing price of $20.34. In other words, the price has decreased by -$0.74 from its previous closing price. On the day, 0.88 million shares were traded. AEHR stock price reached its highest trading level at $20.945 during the session, while it also had its lowest trading level at $19.91.
Ratios:
Our analysis of AEHR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.54 and its Current Ratio is at 7.06. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on December 17, 2025, initiated with a Buy rating and assigned the stock a target price of $29.
On July 17, 2024, Craig Hallum Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $12 to $25.
Craig Hallum Downgraded its Buy to Hold on March 26, 2024, while the target price for the stock was maintained at $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 05 ’25 when SLAYEN HOWARD T sold 6,000 shares for $25.73 per share. The transaction valued at 154,357 led to the insider holds 218,328 shares of the business.
SLAYEN HOWARD T bought 6,000 shares of AEHR for $150,840 on Nov 05 ’25. On Oct 09 ’25, another insider, DANESH FARIBA, who serves as the Director of the company, sold 9,000 shares for $24.79 each. As a result, the insider received 223,101 and left with 16,643 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEHR now has a Market Capitalization of 605833088 and an Enterprise Value of 593740032. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.66 while its Price-to-Book (P/B) ratio in mrq is 4.94. Its current Enterprise Value per Revenue stands at 10.45 whereas that against EBITDA is -105.817.
Stock Price History:
The Beta on a monthly basis for AEHR is 2.33, which has changed by 0.1690793 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, AEHR has reached a high of $34.35, while it has fallen to a 52-week low of $6.27. The 50-Day Moving Average of the stock is -12.73%, while the 200-Day Moving Average is calculated to be 11.82%.
Shares Statistics:
AEHR traded an average of 1.17M shares per day over the past three months and 494040 shares per day over the past ten days. A total of 29.97M shares are outstanding, with a floating share count of 27.85M. Insiders hold about 7.18% of the company’s shares, while institutions hold 68.87% stake in the company. Shares short for AEHR as of 1765756800 were 4824545 with a Short Ratio of 4.11, compared to 1763078400 on 4973671. Therefore, it implies a Short% of Shares Outstanding of 4824545 and a Short% of Float of 17.03.
Earnings Estimates
The dynamic stock of Aehr Test Systems (AEHR) is currently being evaluated by a team of 3.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.02, with high estimates of $0.04 and low estimates of $0.0.
Analysts are recommending an EPS of between $0.12 and $0.01 for the fiscal current year, implying an average EPS of $0.06. EPS for the following year is $0.26, with 3.0 analysts recommending between $0.46 and $0.13.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 4 analysts. It ranges from a high estimate of $12.1M to a low estimate of $11.05M. As of. The current estimate, Aehr Test Systems’s year-ago sales were $13.45MFor the next quarter, 4 analysts are estimating revenue of $16.24M. There is a high estimate of $17.9M for the next quarter, whereas the lowest estimate is $12.4M.
A total of 4 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $63.87M, while the lowest revenue estimate was $49.5M, resulting in an average revenue estimate of $59.28M. In the same quarter a year ago, actual revenue was $58.97MBased on 4 analysts’ estimates, the company’s revenue will be $80.03M in the next fiscal year. The high estimate is $89.1M and the low estimate is $68.7M.
